Holter-Based T Wave Alternans Predicts Sudden Cardiac Death in High-Risk Post-MI Patients

Presentation Start/End Time:

Tuesday, Apr 01, 2008, 10:00 AM -11:00 AM

Topic:

ECG/Ambulatory Monitoring Signal Averaging

Author Block:

Phyllis K. Stein, Peter P. Domitrovich, Devang Sanghavi, Prakash Deedwania, Washington University School of Medicine, St. Louis, MO

Keywords:

Risk prediction,Ambulatory ECG,Heart failure

Background:
Microvolt T-wave alternans (TWA) measured from treadmill testing and using spectral analysis techniques identifies patients at increased risk of sudden death (SCD). TWA can be measured from 24-hour Holter recordings using a time domain method called modified moving average (MMA). The relationship of Holter TWA to SCD is unknown.
Methods:
The design and results of the EPHESUS study have been published previously. EPHESUS enrolled hospitalized post-MI patients with heart failure and/or diabetes with left ventricular dysfunction. Prior to randomization to drug treatment, Holter recordings were obtained from 493 patients. Of these patients, 48 died, 18 suddenly and the rest of cardiovascular causes (nonSCD). A case control study was performed using 92 controls, alive at the end of follow up and matched with non-survivors based on age, gender and having diabetes. MMA TWA analysis was performed using a MARS system (GE Healthcare, Milwaukee, WI) running software version 7.1.1. The software provides a histogram of TWA values and the ECG strips associated with them. The three highest values for TWA from artifact-free periods were identified and averaged (AVMAXTWA) for each channel. The cutpoint that maximized the separation between those who had SCD and those who did not was determined using Cox regression analyses.
Results:
AVMAXTWA on either channel was higher for those who had SCD but not different between nonSCD and survivors. For channel 1, AVMATWA was 38±12 µV for SCD vs. 29±11 µV for survivors and 26±8 µV for nonSCD (p=0.002). For channel 2, AVMATWA was 45±19 µV for SCD vs. 33±19 µV for survivors and 33±13 µV for nonSCD (p=0.05). The best cutpoint for prediction of SCD from AVMAXTWA on channel 1 was 43 µV. AVMAXTWA above this cutpoint identified 14 patients with a nearly six fold risk of sudden death of [RR=5.9 (95% CI= 2.2-15.8, p<0.001)]. Seven of these 14 died, all but one suddenly. The channel 2 cutpoint was 47 µV with a relative risk of sudden death among the 19 patients above this cutpoint of 5.5 (95% CI=2.2-13.8, p<0.001). Eight died suddenly.
Conclusions:
Holter-based TWA measured using MMA appears to be a powerful predictor of SCD in high-risk post-MI patients

Learning Objective 1:

understand the basis for Holter-derived t-wave alternans